Surveillance For New Lung Primaries

This study has been terminated.

Sponsored by:	University of Wisconsin, Madison
Information provided by:	University of Wisconsin, Madison
ClinicalTrials.gov Identifier:	NCT00205439

Purpose

The primary goal of this study is to determine the prevalence of tracheobronchial carcinomas in patients with a history of squamous cell cancer of the aerodigestive tract who have been treated with a curative intent and remain disease free. Detection of pre-invasive and invasive lesions (moderate to severe dysplasia, CIS) with fluorescence bronchoscopic surveillance may help to define the natural history of these lesions and allow earlier intervention should they progress to invasive lesions.

Condition
Lung Cancer

MedlinePlus related topics: Cancer Lung Cancer

U.S. FDA Resources

Study Type:	Observational
Official Title:	Fluorescence Bronchoscopic Surveillance For New Lung Primaries After Curative Therapy for Squamous Cell Carcinoma of the Aerodigestive Tract"

Further study details as provided by University of Wisconsin, Madison:

Estimated Enrollment:	200
Study Start Date:	December 2001

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

History squamous cell NSCLC who have undergone complete resection or definitive chemotherapy

Exclusion Criteria:

History of an aerodigestive tract carcinoma of non-squamous histology
Patients who have Stage IIIA, IIIB or IV squamous cell lung cancer that have undergone resection or chemotherapy within three years
Patients who have Stage I or II squamous cell lung cancer that have undergone resection or chemotherapy within one year
Patients who have received external beam radiation therapy for treatment of a squamous cell cancer of the lung

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00205439

Locations

United States, Wisconsin
University of Wisconsin Hospital and Clinics
Madison, Wisconsin, United States, 53792

Sponsors and Collaborators

University of Wisconsin, Madison

Investigators

Principal Investigator:

Tracey Weigel, MD

University of Wisconsin Medical School

More Information

Study ID Numbers:	2001-431
Study First Received:	September 13, 2005
Last Updated:	December 21, 2007
ClinicalTrials.gov Identifier:	NCT00205439
Health Authority:	United States: Institutional Review Board

Study placed in the following topic categories:

Epidermoid carcinoma
Thoracic Neoplasms
Respiratory Tract Diseases
Lung Neoplasms
Squamous cell carcinoma

Lung Diseases
Carcinoma, squamous cell
Carcinoma, Squamous Cell
Carcinoma

Additional relevant MeSH terms:

Respiratory Tract Neoplasms
Neoplasms
Neoplasms by Site

ClinicalTrials.gov processed this record on January 16, 2009